Besides these transcription factors which are well studied for PPIi, many others are already, or envisaged to be, targeted by peptidomimetics or synthetic inhibitors for cancer treatment (androgen receptor/TIF2, HIF1α/p300-CBP, HOX/PBX, YAP/TEAD) [112,177,178,179,180]. Here, HIF1A is linked to cancer.